Nuvo Pharmaceuticals Inc (MRVFF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,908 | 15,909 | 1,605 | -25,696 | -21,141 |
| Depreciation Amortization | 4,031 | 2,869 | 1,497 | 6,423 | 4,866 |
| Income taxes - deferred | N/A | 1,542 | N/A | 1,917 | N/A |
| Accounts receivable | -2,506 | -2,453 | -2,494 | 799 | -700 |
| Other Working Capital | -1,528 | -2,446 | -2,019 | 3,905 | 926 |
| Other Operating Activity | -8,224 | -11,624 | 774 | 29,285 | 28,226 |
| Operating Cash Flow | $7,680 | $3,796 | $-637 | $16,631 | $12,177 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -45 | -10 | -176 | -94 |
| Purchase Sale Intangibles | -18 | -18 | -18 | -18 | 34 |
| Other Investing Activity | -18 | -18 | -18 | -18 | 34 |
| Investing Cash Flow | $-103 | $-63 | $-28 | $-193 | $-60 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7,606 | -5,247 | -2,746 | -10,693 | -8,165 |
| Other Financing Activity | -130 | -89 | -44 | -180 | -134 |
| Financing Cash Flow | $-7,736 | $-5,335 | $-2,790 | $-10,872 | $-8,299 |
| Exchange Rate Effect | 453 | -193 | 38 | 73 | -161 |
| Beginning Cash Position | 23,656 | 24,177 | 24,378 | 18,996 | 18,912 |
| End Cash Position | 23,951 | 22,382 | 20,960 | 24,634 | 22,569 |
| Net Cash Flow | $295 | $-1,796 | $-3,418 | $5,639 | $3,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,680 | 3,796 | -637 | 16,631 | 12,177 |
| Capital Expenditure | -85 | -45 | -10 | -176 | -94 |
| Free Cash Flow | 7,595 | 3,751 | -648 | 16,456 | 12,083 |